SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-08-049502
Filing Date
2008-03-07
Accepted
2008-03-07 08:52:18
Documents
11
Period of Report
2007-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 20-F d20f.htm 20-F 4404069
2 BYLAWS (STATUTS) OF SANOFI-AVENTIS (ENGLISH TRANSLATION) dex11.htm EX-1.1 41821
3 CERTIFICATION BY GERARD LE FUR, CHIEF EXECUTIVE OFFICER dex121.htm EX-12.1 8948
4 CERTIFICATION BY JEAN-CLAUDE LEROY, PRINCIPAL FINANCIAL OFFICER dex122.htm EX-12.2 9911
5 CERTIFICATION BY GERARD LE FUR, CHIEF EXECUTIVE OFFICER dex131.htm EX-13.1 2913
6 CERTIFICATION BY JEAN-CLAUDE LEROY, PRINCIPAL FINANCIAL OFFICER dex132.htm EX-13.2 3879
7 CONSENT OF ERNST & YOUNG AUDIT dex231.htm EX-23.1 1613
8 CONSENT OF PRICEWATERHOUSECOOPERS AUDIT dex232.htm EX-23.2 2361
9 REPORT OF THE CHAIRMAN OF THE BOARD OF DIRECTORS FOR 2007 dex991.htm EX-99.1 50901
10 EXTRACT FROM THE FRENCH ANNUAL REPORT, SECTION 1.2 "CORPORATE GOVERNANCE" dex992.htm EX-99.2 74909
11 GRAPHIC g72149g19v02.jpg GRAPHIC 79174
  Complete submission text file 0001193125-08-049502.txt   4712029
Mailing Address 174 AVENUE DE FRANCE PARIS I0 75013
Business Address 174 AVENUE DE FRANCE PARIS I0 75013 33153774400
SANOFI-AVENTIS (Filer) CIK: 0001121404 (see all company filings)

IRS No.: 133529324 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-31368 | Film No.: 08672678
SIC: 2834 Pharmaceutical Preparations